DISCOUNT ZERTIFIKAT - INTUITIVE SURGICAL Stock

Certificat

DE000ME7XKW9

Market Closed - Börse Stuttgart 14:08:10 2024-05-31 EDT
343.3 EUR -0.15% Intraday chart for DISCOUNT ZERTIFIKAT - INTUITIVE SURGICAL
1 month+2.04%
3 months+4.82%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 343.3 -0.15%
24-05-30 343.8 -0.08%
24-05-29 344.1 +0.82%
24-05-28 341.3 -0.61%
24-05-27 343.4 -0.03%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 02:08 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying INTUITIVE SURGICAL, INC.
Issuer Morgan Stanley
WKN ME7XKW
ISINDE000ME7XKW9
Date issued 2024-01-30
Cap 375 $
Last trading day 2024-06-21
Maturity 2024-06-21 (20 Days)
Parity 1 : 1
Emission price 324.4
Emission volume N/A
Payment day 2024-06-28
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 7.222 %
Sideways yield 0.5499 %
Sideways yield pa 9.558 %
Outperformance point 404.2 $
Break even 372.95 €
Highest since issue 345.1
Lowest since issue 319.3
Spread 0.24
Spread %0.07%
Distance Cap 27.12 $
Distance Cap %+6.74%
Max. earning 1.891
Max. earning % 0.5499 %

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
402.1 USD
Average target price
423.6 USD
Spread / Average Target
+5.33%
Consensus